EDSA · Company research
Edesa Biotech, Inc. Common Shares (EDSA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| FDA clears a study of patchy skin color loss to expand to U.S. sites. Enrollment is expected next quarter. - Stock Titan | FDA clears a study of patchy skin color loss to expand to U.S. sites. Enrollment is expected next quarter. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| A stock award vested in full upon grant gives Edesa Biotech (EDSA) CEO 6,893 shares. - Stock Titan | A stock award vested in full upon grant gives Edesa Biotech (EDSA) CEO 6,893 shares. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| Edesa Biotech (NasdaqCM:EDSA) Stock Forecast & Analyst Predictions - Simply Wall Street | Edesa Biotech (NasdaqCM:EDSA) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 22, 2026 | neutral | 0 | 0.6 |
| Edesa Biotech Stock Sinks After Fresh Capital Raise - Yahoo Finance | Edesa Biotech Stock Sinks After Fresh Capital Raise Yahoo Finance | View source ↗ | Yahoo Finance | Aug 20, 2026 | neutral | 0 | 0.6 |
| Edesa Biotech Stock Sinks After Fresh Capital Raise - Benzinga | Edesa Biotech Stock Sinks After Fresh Capital Raise Benzinga | View source ↗ | Benzinga | Aug 20, 2026 | neutral | 0 | 0.6 |
| Edesa Biotech stock tumbles on public offering launch - Investing.com | Edesa Biotech stock tumbles on public offering launch Investing.com | View source ↗ | Investing.com | Aug 19, 2026 | neutral | 0 | 0.6 |
| Edesa Biotech Announces Proposed Public Offering of Common Shares and Warrants - Quiver Quantitative | Edesa Biotech Announces Proposed Public Offering of Common Shares and Warrants Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 19, 2026 | neutral | 0 | 0.6 |
| $EDSA stock is down 8% today. Here's what we see in our data. | EDSA Stock News - Quiver Quantitative | $EDSA stock is down 8% today. Here's what we see in our data. | EDSA Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | May 20, 2026 | neutral | 0 | 0.6 |
| EDSA Stock Soars More Than 700% So Far This Year: Wall Street Eyes Further Upside In Run Up To Acute Kidney Injury Data Reveal - Stocktwits | EDSA Stock Soars More Than 700% So Far This Year: Wall Street Eyes Further Upside In Run Up To Acute Kidney Injury Data Reveal Stocktwits | View source ↗ | Stocktwits | May 19, 2026 | neutral | 0 | 0.6 |
| Edesa Biotech, Inc. Common Shares (EDSA) Stock Price: Oct 8 Close $3.66 - Gotrade | Edesa Biotech, Inc. Common Shares (EDSA) Stock Price: Oct 8 Close $3.66 Gotrade | View source ↗ | Gotrade | Apr 30, 2026 | neutral | 0 | 0.6 |
| These stocks are moving in today's session - ChartMill | These stocks are moving in today's session ChartMill | View source ↗ | ChartMill | Apr 27, 2026 | neutral | 0 | 0.6 |
| EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech? - Stocktwits | EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech? Stocktwits | View source ↗ | Stocktwits | Apr 27, 2026 | neutral | 0 | 0.6 |
| Edesa Biotech Reaches US$68m Market Cap Benefiting Insider Stock Buying - Yahoo Finance | Edesa Biotech Reaches US$68m Market Cap Benefiting Insider Stock Buying Yahoo Finance | View source ↗ | Yahoo Finance | Apr 23, 2026 | neutral | 0 | 0.6 |
| $EDSA stock is up 28% today. Here's what we see in our data. | EDSA Stock News - Quiver Quantitative | $EDSA stock is up 28% today. Here's what we see in our data. | EDSA Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Mar 3, 2026 | neutral | 0 | 0.6 |
| Biotech Stock Edesa Biotech (Nasdaq:EDSA) Gains on News of Additional Positive Results from Phase 3 Paridiprubart Study - Investorideas.com | Biotech Stock Edesa Biotech (Nasdaq:EDSA) Gains on News of Additional Positive Results from Phase 3 Paridiprubart Study Investorideas.com | View source ↗ | Investorideas.com | Feb 24, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.